Cargando…
Effects of Short-Term Hydroxychloroquine Plus Moxifloxacin Therapy on Corrected QT Interval and Tp-e Interval in Patients With COVID-19
BACKGROUND: Limited data are available regarding hydroxychloroquine (HCQ) and moxifloxacin (MOX) in patients with possible coronavirus disease 2019, (COVID-19). Both drugs may increase risk of malignant ventricular arrhythmias associated with prolongation of QT interval. METHODS: A total of 76 subje...
Autores principales: | Afsin, Abdulmecit, Ecemis, Kenan, Asoglu, Ramazan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430923/ https://www.ncbi.nlm.nih.gov/pubmed/32849949 http://dx.doi.org/10.14740/jocmr4288 |
Ejemplares similares
-
Evaluation of TP-E Interval and TP-E/QT Ratio in Panic Disorder
por: Afsin, Abdulmecit, et al.
Publicado: (2020) -
QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020) -
Effects of hydroxychloroquine treatment on QT interval
por: Hooks, Matthew, et al.
Publicado: (2020) -
Hydroxychloroquine-associated QT interval prolongation
Publicado: (2020) -
Effect of Dexmedetomidine on the Corrected QT and Tp-e Intervals during Spinal Anesthesia
por: Kim, Youngsoon, et al.
Publicado: (2014)